{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:38:00Z","timestamp":1789144680095,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hyperammonaemia is an important cause for encephalopathy. Ammonia is the waste product of amino acid degradation and cannot be excreted via urine. Ammonia is metabolized to water-soluble urea via the urea cycle. Hyperammonaemia not only occurs during acute liver failure, but also in rare genetically determined defects of enzymes or transporters involved in the urea cycle resulting in elevated ammonia concentrations. Enzyme defects include deficiency of carbamylphosphate synthase, N-acetylglutamate synthase, ornithine transcarbamylase, argininosuccinate lyase and arginase, transporter defects are citrin deficiency and HHH-syndrome. These urea cycle defects (UCD) mostly manifest for the first time during the neonatal period, infancy or childhood, however first clinical manifestations including encephalopathy may be observed in adulthood in milder forms. Therefore, physicians treating adults should be aware of clinical symptoms in UCD to make a timely diagnosis and initiate treatment. In adulthood, clinical symptoms are often uncharacteristic including headache, avoidance of high-protein food, psychiatric symptoms triggered by heavy exercise or delivery of a child, autism, attention deficit, lethargy, developmental delay and epilepsy. Elevated ammonia concentrations in blood are the biochemical hallmark. Some UCDs can be diagnosed at metabolite level, others only at genetic level. Treatment consists of eucaloric, low-protein diet supplemented with essential amino acids and vitamins\/trace elements, and intake of arginine or citrulline. Pharmacological scavengers of nitrogen are benzoate and butyrate. If conservative therapy fails, hemodialysis should be considered. Prompt treatment during acute crises is essential for optimal outcome. Liver transplantation is considered in metabolically unstable patients. For arginase deficiency, enzyme replacement therapy is available.<\/jats:p>","DOI":"10.1007\/s11011-025-01619-5","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T08:33:17Z","timestamp":1745656397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Urea cycle defects in adulthood: clinical presentation, diagnosis and treatment in genetically encoded hepatic metabolic disorders with a potential for encephalopathy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-0852","authenticated-orcid":false,"given":"Anibh Martin","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"1619_CR1","unstructured":"Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML (2003 Apr 29 [updated 2017 Jun 22]) Urea cycle disorders overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds). GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle, pp 1993\u20132024"},{"key":"1619_CR2","doi-asserted-by":"crossref","unstructured":"Ah Mew N, McCarter R, Izem R, Markus A, Gerstein M, Rice K, Sanz J, Le Mons C, Bartos J, Tuchman M (2020) Comparing treatment options for urea cycle disorders [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI)","DOI":"10.25302\/12.20.CER.150227816"},{"issue":"2","key":"1619_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jhep.2010.11.031","volume":"55","author":"CC Aires","year":"2011","unstructured":"Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ, Silva MF (2011) New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. J Hepatol 55(2):426\u2013434. https:\/\/doi.org\/10.1016\/j.jhep.2010.11.031","journal-title":"J Hepatol"},{"issue":"10","key":"1619_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/dmcn.12488","volume":"56","author":"W Amayreh","year":"2014","unstructured":"Amayreh W, Meyer U, Das AM (2014) Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring. Dev Med Child Neurol 56(10):1021\u20131024. https:\/\/doi.org\/10.1111\/dmcn.12488","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"1619_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10545-017-0022-x","volume":"40","author":"J Baruteau","year":"2017","unstructured":"Baruteau J, Jameson E, Morris AA, Chakrapani A, Santra S, Vijay S, Kocadag H, Beesley CE, Grunewald S, Murphy E, Cleary M, Mundy H, Abulhoul L, Broomfield A, Lachmann R, Rahman Y, Robinson PH, MacPherson L, Foster K, Chong WK, Ridout DA, Bounford KM, Waddington SN, Mills PB, Gissen P, Davison JE (2017) Expanding the phenotype in argininosuccinic aciduria: need for new therapies. J Inherit Metab Dis 40(3):357\u2013368. https:\/\/doi.org\/10.1007\/s10545-017-0022-x","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1619_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jmd2.12283","volume":"63","author":"A Bin Sawad","year":"2022","unstructured":"Bin Sawad A, Pothukuchy A, Badeaux M, Hodson V, Bubb G, Lindsley K, Uyei J, Diaz GA (2022) Natural history of arginase 1 deficiency and the unmet needs of patients: a systematic review of case reports. JIMD Rep 63(4):330\u2013340. https:\/\/doi.org\/10.1002\/jmd2.12283","journal-title":"JIMD Rep"},{"issue":"Suppl 1","key":"1619_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ymgme.2010.02.010","volume":"100","author":"O Braissant","year":"2010","unstructured":"Braissant O (2010) Current concepts in the pathogenesis of urea cycle disorders. Mol Genet Metab 100(Suppl 1):S3\u2013S12. https:\/\/doi.org\/10.1016\/j.ymgme.2010.02.010","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1619_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10545-012-9546-2","volume":"36","author":"O Braissant","year":"2013","unstructured":"Braissant O, McLin VA, Cudalbu C (2013) Ammonia toxicity to the brain. J Inherit Metab Dis 36(4):595\u2013612. https:\/\/doi.org\/10.1007\/s10545-012-9546-2","journal-title":"J Inherit Metab Dis"},{"key":"1619_CR9","unstructured":"Camacho J, Rioseco-Camacho N (2012 May 31 [updated 2020 Feb 13])\u00a0Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle, pp 1993\u20132024"},{"issue":"3","key":"1619_CR10","doi-asserted-by":"publisher","first-page":"F216","DOI":"10.1136\/adc.2008.144824","volume":"94","author":"AM Das","year":"2009","unstructured":"Das AM, Illsinger S, Hartmann H, Oehler K, Bohnhorst B, K\u00fchn-Velten WN, L\u00fccke T (2009) Prenatal benzoate treatment in urea cycle defects. Arch Dis Child Fetal Neonatal Ed 94(3):F216\u2013F217. https:\/\/doi.org\/10.1136\/adc.2008.144824","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1619_CR11","doi-asserted-by":"publisher","unstructured":"Diaz GA, Schulze A, McNutt MC, Le\u00e3o-Teles E, Merritt JL 2nd, Enns GM, Batzios S, Bannick A, Zori RT, Sloan LS, Potts SL, Bubb G, Quinn AG (2021) Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. J Inherit Metab Dis 44(4):847\u2013856. https:\/\/doi.org\/10.1002\/jimd.12343","DOI":"10.1002\/jimd.12343"},{"key":"1619_CR12","doi-asserted-by":"publisher","unstructured":"Diez-Fernandez C, R\u00fcfenacht V, Santra S, Lund AM, Santer R, Lindner M, Tangeraas T, Unsinn C, de Lonlay P, Burlina A, van Karnebeek CD, H\u00e4berle J (2016) Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis. Genet Med. 2016 Oct;18(10):991\u20131000.\u00a0https:\/\/doi.org\/10.1038\/gim.2015.201. Erratum in: Genet Med 18(6):649.\u00a0https:\/\/doi.org\/10.1038\/gim.2016.46","DOI":"10.1038\/gim.2015.201"},{"issue":"6","key":"1619_CR13","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/jimd.12090","volume":"42","author":"C Diez-Fernandez","year":"2019","unstructured":"Diez-Fernandez C, Hertig D, Loup M, Diserens G, Henry H, Vermathen P, Nuoffer JM, H\u00e4berle J, Braissant O (2019) Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: an in vitro study in rat three-dimensional organotypic brain cell cultures. J Inherit Metab Dis 42(6):1077\u20131087. https:\/\/doi.org\/10.1002\/jimd.12090","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1619_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jimd.12609","volume":"47","author":"C Duff","year":"2024","unstructured":"Duff C, Alexander IE, Baruteau J (2024) Gene therapy for urea cycle defects: an update from historical perspectives to future prospects. J Inherit Metab Dis 47(1):50\u201362. https:\/\/doi.org\/10.1002\/jimd.12609","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1619_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10545-006-0120-7","volume":"29","author":"S Fecarotta","year":"2006","unstructured":"Fecarotta S, Parenti G, Vajro P, Zuppaldi A, Della Casa R, Carbone MT, Correra A, Torre G, Riva S, Dionisi-Vici C, Santorelli FM, Andria G (2006) HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation. J Inherit Metab Dis 29(1):186\u2013189. https:\/\/doi.org\/10.1007\/s10545-006-0120-7","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"1619_CR16","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s10072-012-1266-8","volume":"34","author":"M Filosto","year":"2013","unstructured":"Filosto M, Alberici A, Tessa A, Padovani A, Santorelli FM (2013) Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome in adulthood: a rare recognizable condition. Neurol Sci 34(9):1699\u20131701. https:\/\/doi.org\/10.1007\/s10072-012-1266-8","journal-title":"Neurol Sci"},{"issue":"6","key":"1619_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, Skouma A, Servais A, Tal G, Rubio V, Huemer M, Dionisi-Vici C (2019) Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis 42(6):1192\u20131230. https:\/\/doi.org\/10.1002\/jimd.12100","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"1619_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jhep.2022.10.013","volume":"78","author":"M Kasahara","year":"2023","unstructured":"Kasahara M, Hong JC, Dhawan A (2023) Evaluation of living donors for hereditary liver disease (siblings, heterozygotes). J Hepatol 78(6):1147\u20131156. https:\/\/doi.org\/10.1016\/j.jhep.2022.10.013","journal-title":"J Hepatol"},{"issue":"6","key":"1619_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jimd.12415","volume":"44","author":"J Kido","year":"2021","unstructured":"Kido J, Matsumoto S, H\u00e4berle J, Inomata Y, Kasahara M, Sakamoto S, Horikawa R, Tanemura A, Okajima H, Suzuki T, Nakamura K (2021) Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan. J Inherit Metab Dis 44(6):1311\u20131322. https:\/\/doi.org\/10.1002\/jimd.12415","journal-title":"J Inherit Metab Dis"},{"key":"1619_CR20","doi-asserted-by":"publisher","unstructured":"Komatsu M, Tanaka N, Kimura T, Yazaki M (2023) Citrin deficiency: clinical and nutritional features. Nutrients 15(10):2284. https:\/\/doi.org\/10.3390\/nu15102284","DOI":"10.3390\/nu15102284"},{"key":"1619_CR21","doi-asserted-by":"publisher","first-page":"1431008","DOI":"10.3389\/fped.2024.1431008","volume":"12","author":"Y Maghmoul","year":"2024","unstructured":"Maghmoul Y, Wiedemann A, Barcat L, Parente F, Allard P, Alvarez F, Jouvet P (2024) Hyperosmolarity in children with hyperammonemia: a risk of brain herniation at the start of renal replacement therapy. Front Pediatr 12:1431008. https:\/\/doi.org\/10.3389\/fped.2024.1431008","journal-title":"Front Pediatr"},{"issue":"4","key":"1619_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ymgme.2010.08.002","volume":"101","author":"AI Mart\u00ednez","year":"2010","unstructured":"Mart\u00ednez AI, P\u00e9rez-Arellano I, Pekkala S, Barcelona B, Cervera J (2010) Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab 101(4):311\u2013323. https:\/\/doi.org\/10.1016\/j.ymgme.2010.08.002","journal-title":"Mol Genet Metab"},{"issue":"7","key":"1619_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jcph.92","volume":"53","author":"JP Monteleone","year":"2013","unstructured":"Monteleone JP, Mokhtarani M, Diaz GA, Rhead W, Lichter-Konecki U, Berry SA, Lemons C, Dickinson K, Coakley D, Lee B, Scharschmidt BF (2013) Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders. J Clin Pharmacol 53(7):699\u2013710. https:\/\/doi.org\/10.1002\/jcph.92","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"1619_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4103\/aian.aian_1028_21","volume":"25","author":"VK Nambiar","year":"2022","unstructured":"Nambiar VK, Shridharani A, Kannoth S, Gopinath S, Kumar A (2022) Acute fulminant encephalopathy in an adult due to ornithine transcarbamylase deficiency. Ann Indian Acad Neurol 25(4):722\u2013724. https:\/\/doi.org\/10.4103\/aian.aian_1028_21","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"1619_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10545-005-0303-7","volume":"28","author":"MC Nassogne","year":"2005","unstructured":"Nassogne MC, H\u00e9ron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28(3):407\u2013414. https:\/\/doi.org\/10.1007\/s10545-005-0303-7","journal-title":"J Inherit Metab Dis"},{"key":"1619_CR26","doi-asserted-by":"publisher","unstructured":"Nteli D, Nteli M, Konstantinidis K, Foka A, Charisi F, Michailidou I, Stavropoulou De Lorenzo S, Boziki M, Tzitiridou-Chatzopoulou M, Spandou E et al (2024) Argininemia: pathophysiology and novel methods for evaluation of the disease. Appl Sci 14:1647. https:\/\/doi.org\/10.3390\/app14041647","DOI":"10.3390\/app14041647"},{"issue":"1","key":"1619_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1941874418764817","volume":"9","author":"MA Pizzi","year":"2019","unstructured":"Pizzi MA, Alejos D, Hasan TF, Atwal PS, Krishnaiengar SR, Freeman WD (2019) Adult presentation of ornithine transcarbamylase deficiency: 2 illustrative cases of phenotypic variability and literature review. Neurohospitalist 9(1):30\u201336. https:\/\/doi.org\/10.1177\/1941874418764817","journal-title":"Neurohospitalist"},{"issue":"1","key":"1619_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.25492","volume":"86","author":"R Posset","year":"2019","unstructured":"Posset R, Gropman AL, Nagamani SCS, Burrage LC, Bedoyan JK, Wong D, Berry GT, Baumgartner MR, Yudkoff M, Zielonka M, Hoffmann GF, Burgard P, Schulze A, McCandless SE, Garcia-Cazorla A, Seminara J, Garbade SF, K\u00f6lker S (2019) Urea cycle disorders consortium and the European registry and network for intoxication type metabolic diseases consortia study group. Impact of diagnosis and therapy on cognitive function in Urea cycle disorders. Ann Neurol 86(1):116\u2013128. https:\/\/doi.org\/10.1002\/ana.25492","journal-title":"Ann Neurol"},{"issue":"6","key":"1619_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1177\/0883073814535490","volume":"30","author":"P Prasun","year":"2015","unstructured":"Prasun P, Altinok D, Misra VK (2015) Ornithine transcarbamylase deficiency presenting with acute reversible cortical blindness. J Child Neurol 30(6):782\u2013785. https:\/\/doi.org\/10.1177\/0883073814535490","journal-title":"J Child Neurol"},{"issue":"5","key":"1619_CR30","doi-asserted-by":"publisher","first-page":"e17157","DOI":"10.15252\/emmm.202217157","volume":"15","author":"M Preu\u00dfner","year":"2023","unstructured":"Preu\u00dfner M, Smith HL, Hughes D, Zhang M, Emmerichs AK, Scalzitti S, Peretti D, Swinden D, Neumann A, Haltenhof T, Mallucci GR, Heyd F (2023) ASO targeting RBM3 temperature-controlled poison exon splicing prevents neurodegeneration in vivo. EMBO Mol Med 15(5):e17157. https:\/\/doi.org\/10.15252\/emmm.202217157","journal-title":"EMBO Mol Med"},{"issue":"8","key":"1619_CR31","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s10571-021-01156-6","volume":"42","author":"GS Ribas","year":"2022","unstructured":"Ribas GS, Lopes FF, Deon M, Vargas CR (2022) Hyperammonemia in inherited metabolic diseases. Cell Mol Neurobiol 42(8):2593\u20132610. https:\/\/doi.org\/10.1007\/s10571-021-01156-6","journal-title":"Cell Mol Neurobiol"},{"key":"1619_CR32","doi-asserted-by":"publisher","first-page":"102405","DOI":"10.1016\/j.eclinm.2023.102405","volume":"68","author":"RS Russo","year":"2024","unstructured":"Russo RS, Gasperini S, Bubb G, Neuman L, Sloan LS, Diaz GA, Enns GM (2024) PEACE investigators. Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial. EClinicalMedicine 68:102405. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102405","journal-title":"EClinicalMedicine"},{"key":"1619_CR33","unstructured":"Saheki T, Song YZ (2005 Sep 16 [updated 2017 Aug 10]) Citrin deficiency. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle, pp 1993\u20132024"},{"issue":"Suppl 1","key":"1619_CR34","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ymgme.2004.01.006","volume":"81","author":"T Saheki","year":"2004","unstructured":"Saheki T, Kobayashi K, Iijima M, Horiuchi M, Begum L, Jalil MA, Li MX, Lu YB, Ushikai M, Tabata A, Moriyama M, Hsiao KJ, Yang Y (2004) Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by Citrin deficiency: involvement of the aspartate glutamate carrier for Urea synthesis and maintenance of the urea cycle. Mol Genet Metab 81(Suppl 1):S20\u2013S26. https:\/\/doi.org\/10.1016\/j.ymgme.2004.01.006","journal-title":"Mol Genet Metab"},{"issue":"9","key":"1619_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00726-015-2032-z","volume":"47","author":"A Schlune","year":"2015","unstructured":"Schlune A, Vom Dahl S, H\u00e4ussinger D, Ensenauer R, Mayatepek E (2015) Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids 47(9):1751\u20131762. https:\/\/doi.org\/10.1007\/s00726-015-2032-z","journal-title":"Amino Acids"},{"issue":"1","key":"1619_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13023-024-03167-0","volume":"19","author":"RH Singh","year":"2024","unstructured":"Singh RH, Bourdages MH, Kurtz A, MacLoed E, Norman C, Ratko S, van Calcar SC, Kenneson A (2024) The efficacy of carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency. Orphanet J Rare Dis 19(1):168. https:\/\/doi.org\/10.1186\/s13023-024-03167-0","journal-title":"Orphanet J Rare Dis"},{"issue":"4 Suppl","key":"1619_CR37","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.ccc.2005.05.007","volume":"21","author":"W Smith","year":"2005","unstructured":"Smith W, Kishnani PS, Lee B, Singh RH, Rhead WJ, Sniderman King L, Smith M, Summar M (2005) Urea cycle disorders: clinical presentation outside the newborn period. Crit Care Clin 21(4 Suppl):S9\u201317. https:\/\/doi.org\/10.1016\/j.ccc.2005.05.007","journal-title":"Crit Care Clin"},{"issue":"4 Suppl","key":"1619_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ccc.2005.05.002","volume":"21","author":"ML Summar","year":"2005","unstructured":"Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH, Rhead WJ, Sniderman King L, Christman BW (2005) Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin 21(4 Suppl):S1\u20138. https:\/\/doi.org\/10.1016\/j.ccc.2005.05.002","journal-title":"Crit Care Clin"},{"issue":"10","key":"1619_CR39","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1651-2227.2008.00952.x","volume":"97","author":"ML Summar","year":"2008","unstructured":"Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 97(10):1420\u20131425. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.00952.x","journal-title":"Acta Paediatr"},{"key":"1619_CR40","doi-asserted-by":"publisher","unstructured":"Summar ML, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee HS, Kirmse B, European Registry and Network for Intoxication Type Metabolic Diseases (E-IMD)\u00a0(2013)\u00a0Electronic address: http:\/\/www.e-imd.org\/en\/index.phtml; Members of the Urea Cycle Disorders Consortium (UCDC). Electronic address: http:\/\/rarediseasesnetwork.epi.usf.edu\/ucdc\/. The incidence of urea cycle disorders. Mol Genet Metab 110(1-2):179-80. https:\/\/doi.org\/10.1016\/j.ymgme.2013.07.008","DOI":"10.1016\/j.ymgme.2013.07.008"},{"issue":"3","key":"1619_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ajhg.2014.01.006","volume":"94","author":"CD van Karnebeek","year":"2014","unstructured":"van Karnebeek CD, Sly WS, Ross CJ, Salvarinova R, Yaplito-Lee J, Santra S, Shyr C, Horvath GA, Eydoux P, Lehman AM, Bernard V, Newlove T, Ukpeh H, Chakrapani A, Preece MA, Ball S, Pitt J, Vallance HD, Coulter-Mackie M, Nguyen H, Zhang LH, Bhavsar AP, Sinclair G, Waheed A, Wasserman WW, Stockler-Ipsiroglu S (2014) Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. Am J Hum Genet 94(3):453\u2013461. https:\/\/doi.org\/10.1016\/j.ajhg.2014.01.006","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1619_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10545-016-9942-0","volume":"39","author":"SE Waisbren","year":"2016","unstructured":"Waisbren SE, Gropman AL, Members of the Urea Cycle Disorders Consortium (UCDC), Batshaw ML (2016) Improving long term outcomes in urea cycle disorders-report from the urea cycle disorders consortium. J Inherit Metab Dis 39(4):573\u2013584. https:\/\/doi.org\/10.1007\/s10545-016-9942-0","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1619_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12920-023-01569-w","volume":"16","author":"S Wang","year":"2023","unstructured":"Wang S, Chen J, Zhu X, Huang T, Xu H, Ying G, Qian H, Lin W, Tung Y, Khan KU, Guo H, Zheng G, Lu H, Zhang G (2023) Clinical and genetic analysis of a case of late onset carbamoyl phosphate synthase I deficiency caused by CPS1 mutation and literature review. BMC Med Genomics 16(1):145. https:\/\/doi.org\/10.1186\/s12920-023-01569-w","journal-title":"BMC Med Genomics"},{"key":"1619_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/8904_2018_132","volume":"44","author":"KT Wild","year":"2019","unstructured":"Wild KT, Ganetzky RD, Yudkoff M, Ierardi-Curto L (2019) Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome causing severe neonatal hyperammonemia. JIMD Rep 44:103\u2013107. https:\/\/doi.org\/10.1007\/8904_2018_132","journal-title":"JIMD Rep"},{"issue":"5","key":"1619_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/oxfordjournals.jbchem.a124826","volume":"117","author":"Y Yu","year":"1995","unstructured":"Yu Y, Terada K, Nagasaki A, Takiguchi M, Mori M (1995) Preparation of recombinant argininosuccinate synthetase and argininosuccinate lyase: expression of the enzymes in rat tissues. J Biochem 117(5):952\u2013957. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124826","journal-title":"J Biochem"},{"issue":"3","key":"1619_CR46","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/ijms22031217","volume":"22","author":"M Zabulica","year":"2021","unstructured":"Zabulica M, Jakobsson T, Ravaioli F, Vosough M, Gramignoli R, Ellis E, Rooyackers O, Strom SC (2021) Gene editing correction of a urea cycle defect in organoid stem cell derived hepatocyte-like cells. Int J Mol Sci 22(3):1217. https:\/\/doi.org\/10.3390\/ijms22031217","journal-title":"Int J Mol Sci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01619-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:26:33Z","timestamp":1750915593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01619-5","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}